Proceed cautiously to make sure that we are not jeopardising patient safety
Scientia Advisors in the News
Jonathan Pan quoted by Chemistry World on the FDA's proposed biosimilars approval pathway
February 13, 2012Jonathan Pan of Scientia Advisors was recently quoted in Chemistry World on the FDA guidelines to assist in development and approval of biosimilars.
Read the full interview FDA proposes biosimilars approval pathway.
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
